Journals / KONURALP TIP DERGİSİ / 2023 / Cilt: 15 - Sayı: 1

A new predictor for prediabetes: Chemerin

Prediyabet için yeni bir prediktör: Kimerin

Pages
52–58
Publication Date
2023-03-15
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Studies aimed at irisin and chemerin may provide important role to prevent the prediabetes to Type 2 diabetes progression.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: It was aimed to investigate irisin and chemerin levels in prediabetic individuals and their value in predicting prediabetes.
📊
Key Findings & Data:Method: Thirty-eight prediabetic patients aged 18-65 years (22 impaired fasting glucose (IFG), 10 impaired glucose tolerance (IGT), 6 patients with coexisting IFG and IGT) and thirty-five healthy volunteers were included in which was designed as a cross-sectional study.
💡
Conclusion & Impact:Studies aimed at irisin and chemerin may provide important role to prevent the prediabetes to Type 2 diabetes progression.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Kimerin · Diyabetes mellitus · İrisin

Abstract

Objective: It was aimed to investigate irisin and chemerin levels in prediabetic individuals and their value in predicting prediabetes. Method: Thirty-eight prediabetic patients aged 18-65 years (22 impaired fasting glucose (IFG), 10 impaired glucose tolerance (IGT), 6 patients with coexisting IFG and IGT) and thirty-five healthy volunteers were included in which was designed as a cross-sectional study. The basic demographic characteristics of all participants in the case and control groups were compared with the serum chemerin, irisin, creatinine, aspartate aminotransferase (AST), alanine aminotransferase (ALT), high-density lipoprotein (HDL-cholesterol), low-density lipoprotein (LDL-cholesterol), triglyceride (TG), free thyroxine (sT4), and thyroid-stimulating hormone (TSH) levels. Result: Serum chemerin level was found to be higher in the prediabetic group (p=0.03), while no significant difference was found for the irisin level between the two groups. In the multivariate logistic regression analysis, we showed that chemerin was an independent risk factor in predicting prediabetes. There was a positive correlation (p=0.01, r=0.279) between all participants' body mass index (BMI) and chemerin level and a negative correlation between irisin level and high-density lipoprotein cholesterol (HDL-C) level, and Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) (p=0.04 r=-0.295, p=0.01 r=-0.407, respectively). Conclusion: Chemerin is a new generation chemokine that predicts prediabetes. Studies aimed at irisin and chemerin may provide important role to prevent the prediabetes to Type 2 diabetes progression.

Özet

Amaç: Prediyabetik bireylerde irisin ve kimerin düzeylerini ve bunların prediyabeti öngörmedeki değerini araştırmak amaçlandı. Metod: Kesitsel bir çalışma olan dizayn edilen çalışmamıza; 18-65 yaş arası 38 prediyabetik hasta (22 bozulmuş açlık glukozu (IFG), 10 bozulmuş. glukoz toleransı (IGT), 6 IFG ve IGT birlikte bulunan hasta) ve 35 gönüllü sağlıklı kişi dahil edildi. Vaka ve kontrol grubundaki tüm katılımcıların temel demografik özellikleri ile serum kimerin, irisin, kreatinin, Alanin Aminotransferaz (ALT), Aspartat Aminotransferaz (AST), düşük dansiteli lipoprotein (LDL-kolesterol), yüksek dansiteli lipoprotein (HDL-kolesterol), trigliserit (TG), serbest tiroksin (sT4) ve tiroid stimülan hormon (TSH) düzeylerinin sonuçları karşılaştırıldı. Bulgular: Her iki grup arasında irisin düzeyi için fark saptanmazken, kimerin düzeyi prediyabetik grupta daha yüksek saptandı (p=0.03). Yaptığımız çok değişkenli lojistik regresyon analizinde kimerinin prediyabeti ön gördürücü bağımsız bir risk faktörü olduğunu gösterdik. Ayrıca tüm katılımcıların beden kitle indeksi (BKİ) ile kimerin düzeyi arasında pozitif korelasyon (p=0.01, r=0.279); irisin düzeyi ile high density lipoprotein kolesterol (HDL-C) düzeyi ve Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) arasında negatif korelasyon (sırasıyla; p=0.04 r=-0.295, p=0.01 r=-0.407) saptadık. Sonuç: Kimerin prediyabeti predikte eden yeni nesil bir kemokindir. İrisin ve kimerin hedefli yeni çalışmalar prediyabetin diyabete dönüşmesinin önlenmesinde önemli aşamalar sağlayabilir.

🔖

Cite This Article

ERGÜN, E., KOCA, A. O., BEYAN, E., ERTUĞRUL, D. T., AKKAN, T., DAL, K. (2023). A new predictor for prediabetes: Chemerin. KONURALP TIP DERGİSİ, Cilt: 15 - Sayı: 1, 52–58. https://ajindex.com/articles/886980

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N et al.; IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 th edition. Diabetes Res Clin Pract. 2019;157:107843
  2. Perreault L, Pan Q, Mather KJ, Watson KE, Hamman RF, Kahn SE. Diabetes Prevention Program Research Group. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet. 2012;379:2243-51
  3. Bobbert T, Schwarz F, Fischer-Rosinsky A, Maurer L, Möhlig M, Pfeiffer AFH et al. Chemerin and prediction of Diabetes mellitus type 2. Clin Endocrinol (Oxf). 2015;82:838-43
  4. Shetty S, Kusminski CM, Scherer PE. Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies. Trends Pharmacol Sci. 2009;30:234-9
  5. Aydin S. Three new players in energy regulation: preptin, adropin and irisin. Peptides. 2014;56:94-110
  6. Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481:463-8
  7. Stejskal D, Karpisek M, Hanulova Z, Svestak M. Chemerin is an independent marker of the metabolic syndrome in a Caucasian population--a pilot study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2008;152:217-21
  8. Takahashi M, Okimura Y, Iguchi G, Nishizawa H, Yamamoto M, Suda K et al. Chemerin regulates β-cell function in mice. Sci Rep. 2011;1:123
  9. Lee MK, Chu SH, Lee DC, An KY, Park J-H, Kim DI et al. The association between chemerin and homeostasis assessment of insulin resistance at baseline and after weight reduction via lifestyle modifications in young obese adults. Clin Chim Acta. 2013;421:109-15
  10. American Diabetes Association
  11. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021;44:15-33
  12. Morris MR, Ludwar BCh, Swingle E, Mamo MN, Shubrook JH. A New Method to Assess Asymmetry in Fingerprints Could Be Used as an Early Indicator of Type 2 Diabetes Mellitus. J Diabetes Sci Technol. 2016;10:864-71
  13. Castro AV, Kolka CM, Kim SP, Bergman RN. Obesity, insulin resistance and comorbidities? Mechanisms of association. Arq Bras Endocrinol Metabol. 2014;58:600-9
  14. Weigert J, Neumeier M, Wanninger J, Filarsky M, Bauer S, Wiest R e